Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotorSona M. Vora, Stephen Boyd, Nicholas Denny, Elizabeth Jackson,Noemi B. A. Roy,Jo Howard,Sanne LugthartBRITISH JOURNAL OF HAEMATOLOGY（2022）引用 1|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
